Briefing on $1 billion Knight cancer challenge
09/23/13 Portland, Ore.
Oregon Health & Science University and its Knight Cancer Institute to share details on vision for $1 billion cancer challenge from Nike Chairman Phil Knight and his wife, Penny
Press conference with Oregon Health & Science University (OHSU) leaders on response to the surprise $500 million matching pledge from the Knights, including overview of 10-year research vision for its Knight Cancer Institute. Phil Knight announced the pledge at the cancer institute’s biennial gala, Friday, Sept. 20.
10:30 a.m. PST, Tuesday, Sept. 24; Opening remarks will start at 10:30 a.m. followed by a question-and answer-session. A conference call will begin at 11:30 a.m. for members of the media who can’t attend. Participant dial-in instructions: 800.434.1335, conference code 994624#.
Press conference will be held in the first level atrium at OHSU’s Center for Health & Healing, 3303 S.W. Bond Ave., Portland.
About the Knight Cancer Institute
The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of personalized cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down cells that enable cancer to grow without harming healthy cells. This breakthrough has made once-fatal forms of the disease manageable and ushered in a new generation of targeted cancer therapies. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It offers the latest treatments and technologies as well as hundreds of research studies and clinical trials.
Oregon Health & Science University is a nationally prominent research university and Oregon’s only public academic health center. It serves patients throughout the region with a Level 1 trauma center and nationally recognized Doernbecher Children’s Hospital. OHSU operates dental, medical, nursing and pharmacy schools that rank high both in research funding and in meeting the university’s social mission. OHSU’s Knight Cancer Institute helped pioneer personalized medicine through a discovery that identified how to shut down cells that enable cancer to grow without harming healthy ones. OHSU Brain Institute scientists are nationally recognized for discoveries that have led to a better understanding of Alzheimer’s disease and new treatments for Parkinson’s disease, multiple sclerosis and stroke. OHSU’s Casey Eye Institute is a global leader in ophthalmic imaging, and in clinical trials related to eye disease.